Page last updated: 2024-08-21

allylglycine and Shock, Septic

allylglycine has been researched along with Shock, Septic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dagvadorj, J; Hiwasa, T; Iftakhar-E-Khuda, I; Koide, N; Komatsu, T; Naiki, Y; Ookoshi, M; Tumurkhuu, G; Yokochi, T; Yoshida, T	1

Other Studies

1 other study(ies) available for allylglycine and Shock, Septic

Article	Year
ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock. Innate immunity, 2011, Volume: 17, Issue:1 Topics: Allylglycine; Animals; Benzamidines; Cell Line, Tumor; Culture Media, Conditioned; Esters; Female; Gabexate; Gene Expression; Guanidines; I-kappa B Proteins; Interferon Regulatory Factor-3; Interferon-gamma; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Serine Proteases; Serine Proteinase Inhibitors; Shock, Septic; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2011

Article

Year

ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock.

Innate immunity, 2011, Volume: 17, Issue:1

Topics: Allylglycine; Animals; Benzamidines; Cell Line, Tumor; Culture Media, Conditioned; Esters; Female; Gabexate; Gene Expression; Guanidines; I-kappa B Proteins; Interferon Regulatory Factor-3; Interferon-gamma; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Serine Proteases; Serine Proteinase Inhibitors; Shock, Septic; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2011